Kaleidoscope develops microarray and sequencing workflows that allow researchers to profile 1000+ genetic and protein markers simultaneously from tissue samples. The team, based in Sydney and UNSW's BioPark, supports clinical trial design and drug development across Australian and international pharmaceutical sponsors.